Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Stavros Peroukidis"'
Autor:
Chaido Sirinian, Anastasios D. Papanastasiou, Ozge Karayel, Soren E. Degn, Stavros Peroukidis, Dimitrios Chaniotis, Afrodite Nonni, Maria Repanti, Mark Kriegsmann, Thomas Makatsoris, Angelos Koutras, Matthias Mann, Haralabos P. Kalofonos
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 33, Iss , Pp 100836- (2022)
Breast cancer is a highly heterogeneous disease both at the histological and molecular levels. We have previously shown that RANK-c is a regulator of NF-κB signaling and exerts a suppressive effect on aggressive properties of ER negative breast canc
Externí odkaz:
https://doaj.org/article/5f86f086b12f4ca3a84b02b36b1aed58
Autor:
Anastasios Papanastasiou, Chaido Sirinian, Maria Theakou, Stavros Peroukidis, Dimitrios Chaniotis, Haralabos Kalofonos, Angelos Koutras
Publikováno v:
Cancer Research. 83:P2-26
TRAF3 (TNF Receptor Associated Factor 3) is a regulator of NF-κB signaling, acting mainly as an inhibitor of the alternative NF-κB pathway through the interaction with other TRAF molecules and the downregulation of NIK (MAP3K14) kinase. While NF-κ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26b89fbf8450db4b31c780230ac40e5c
https://doi.org/10.1158/1538-7445.sabcs22-p2-26-03
https://doi.org/10.1158/1538-7445.sabcs22-p2-26-03
Autor:
Chaido Sirinian, Stavros Peroukidis, Katharina Kriegsmann, Dimitrios Chaniotis, Angelos Koutras, Mark Kriegsmann, Anastasios D. Papanastasiou
Publikováno v:
Genes. 13:994
Cellular senescence (CS) is a major homeostatic biological process, which plays a key role in normal tissue development and provides protection from stressful cell insults. The role of CS in mammary-gland development and breast cancer is not well und
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8cfbf96a51e37d9fd5e6de98c29653a
https://doi.org/10.3390/genes13060994
https://doi.org/10.3390/genes13060994
Autor:
Michael Liontos, Eleni Timotheadou, Emmanouil S. Saloustros, Anna Koumarianou, Ilias Athanasiadis, Sofia Karageorgopoulou, Pavlos Papakotoulas, Ioannis Syrios, Georgios Kesisis, Christos Papadimitriou, Eirini Biziota, Maria Skondra, Stylianos Giassas, Eleftherios Kampletsas, Stavros Peroukidis, Christos Christodoulou, Fotini Papageorgiou, Ioannis Boukovinas, Zacharenia Saridaki
Publikováno v:
Journal of Clinical Oncology. 40:e18520-e18520
e18520 Background: Homologous Recombination deficiency (HRD) represents a distinct entity in OC. Clinical data suggest that treatment selection can be based on both BRCA1/2 mutations and bearing Genomic Instability Status (GIS). Testing for GIS is cr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0026eb4734eebca665ff3f6a5f157ec
https://doi.org/10.1200/jco.2022.40.16_suppl.e18520
https://doi.org/10.1200/jco.2022.40.16_suppl.e18520
Autor:
Nikolaos Tsoukalas, Athina Christopoulou, Anna Koumarianou, Eleni Timotheadou, Ilias Athanasiadis, Georgios Samelis, Stavros Peroukidis, Amanda Psyrri, Nikolaos Kapodistrias, Achilleas Nikolakopoulos, Stamatina G Demiri, Charalampos Andreadis, Alexandros Bokas, Alexandros Ardavanis, Epaminondas Samantas, Dimitrios Mavroudis, Vasileios Barbounis, Athanasios Athanasiadis, Pavlos Papakotoulas, Ioannis Boukovinas
Publikováno v:
Journal of Clinical Oncology. 40:e18677-e18677
e18677 Background: Venous ThromboEmbolism (VTE), might be a challenge with a lot of negative consequences for patients with active cancer. VTE affects ongoing anticancer treatment, worsening morbidity and mortality, increases economic burden and esca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67a7154a0138fea38f9d95de5fa2a6ee
https://doi.org/10.1200/jco.2022.40.16_suppl.e18677
https://doi.org/10.1200/jco.2022.40.16_suppl.e18677
Publikováno v:
International Journal of Case Reports. :159
Metastatic pancreatic adenocarcinoma to the urinary bladder is extremely rare and has only been reported 4 cases worldwide. We describe such a case presented with hematuria and dysuria after ten months of the initial diagnosis. Immunohistochemistry h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b45658ae53a6e9adccc71bbabe38adf
https://doi.org/10.28933/ijcr-2020-08-2905
https://doi.org/10.28933/ijcr-2020-08-2905